Screening of 2,000 Tysabri patients finds no new cases of brain disease

DUBLIN, Ireland (AP) - About 2,000 patients who took the suspended MS-fighting drug Tysabri in clinical trials have been screened for a deadly disease, but none showed signs of contracting it, the Irish and U.S. companies jointly developing the drug said Tuesday. Elan Corp....More